. Author manuscript; available in PMC: 2010 Oct 1.

Published in final edited form as: Pediatr Blood Cancer. 2009 Oct;53(4):622–628. doi: 10.1002/pbc.22101

Table III.

Comparison of mean ADL motor and ADL process ability measures (+95% confidence intervals) for treatment subgroups (among sarcoma survivors) and age matched comparisons. (p<0.05)

		Mean ± 95% confidence interval
Groups	Sample size	ADL Motor Ability Measures (logits)	ADL Process Ability Measures (logits)
Well adults matched for age and gender	32	3.08 (2.92, 3.25)	2.28 (2.11, 2.44)
Sarcoma survivors: (N=32)
Total body radiation	7	2.52 (1.61, 3.43)	1.49 (1.28, 1.70)^†
Cranial radiation	6	2.38 (1.69, 3.06)^†	1.74 (1.52, 1.96)^†
Whole lung radiation	5	2.82 (2.09, 3.55)	1.68 (1.25, 2.11)^†
Local irradiation	10	3.29 (2.88, 3.69)	1.86 (1.64, 2.08)^†
No irradiation (surgery only)	4	2.37 (1.86, 2.88)	1.56 (1.21, 1.90)^†

^†

Significantly lower than age and gender matched comparisons